| Document |
Document Title |
|
WO/2022/194189A1 |
Provided in the present invention is a Lactobacillus Bangia fusco-purpurea fermentation supernatant having an α-glucosidase inhibitory activity. The method for preparing the Lactobacillus Bangia fusco-purpurea fermentation supernatant c...
|
|
WO/2022/197241A1 |
The present invention relates to a Bacillus subtilis strain isolate DSM33646 which is capable of propagating and secreting mannolytic enzymes to hydrolyse at least three forms of mannan polymers upon contact with solvent- extracted palm ...
|
|
WO/2022/195075A1 |
The present invention relates to the identification of a novel isolated lactic acid bacterial species. More specifically, a novel Latilactobacillus species, Latilactobacillus fragifolii sp. nov., with the type strain AMBP162T is proposed...
|
|
WO/2022/193398A1 |
Provided are a trivalent dimethylarsinous acid induced human keratinocyte malignant transformation cell strain, and the use thereof, which belong to the technical field of model construction. An inorganic arsenic metabolite trivalent dim...
|
|
WO/2022/192956A1 |
The present disclosure relates to compositions and methods for inducing encystment of and/or stabilising ciliate cells. In particular, the present disclosure relates to polymers and polymeric solutions, including hydrocolloids, which may...
|
|
WO/2022/193163A1 |
Provided are streptococcus thermophilus for producing γ-aminobutyric acid and an application thereof. The streptococcus thermophilus for producing γ-aminobutyric acid is named Streptomyces thermophilus ST 36 and is preserved in the Ins...
|
|
WO/2022/197957A1 |
An integrated process and corresponding apparatus that produces a relatively clean, delignified cellulose product from lignocellulosic biomass. The method includes treating a portion of the delignified cellulose itself as a substrate to ...
|
|
WO/2022/190022A1 |
Ascomycetous filamentous fungi genetically modified to produce proteins having reduced or no N-glycans of mammalian proteins are provided, comprising deletion or disruption of stt3 and/or cwh8 genes.
|
|
WO/2022/188834A1 |
Disclosed in the present invention are a method for strengthening biogenic manganese oxidation by using a magnetic field, and an application thereof. Manganese-oxidizing bacteria are inoculated into a culture medium containing Mn2+, magn...
|
|
WO/2022/188378A1 |
Provided is a method for preparing a quality control sphere of freeze-dried Escherichia coli. The method comprises the following steps: preparing bacterial sludge containing Escherichia coli, preparing a freeze-drying protective agent, u...
|
|
WO/2022/188403A1 |
Provided are a strain of Enterobacter chengduensis for producing nicotinamide mononucleotide (NMN) and the use thereof. The Enterobacter chengduensis is prepared by means of collecting soil from near a sewer of a factory for producing NM...
|
|
WO/2022/188162A1 |
Provided are an endophytic fungus in Ginkgo biloba, i.e., Fusarium oxysporum DZHQ2, and an anti-bacterial and antitumor application thereof. The preservation number of the Fusarium oxysporum is CCTCC No. M 2021211. A crude extract of a f...
|
|
WO/2022/188783A1 |
Provided are a construction method and application of an F gene-replaced chimeric measles attenuated strain. Specifically, the present invention provides a chimeric measles virus attenuated strain, and the attenuated strain is a measles ...
|
|
WO/2022/188784A1 |
Provided are a construction method for an H-gene-replaced chimeric measles attenuated strain and an application thereof. The attenuated strain is a measles virus rMV/H(H1a) having an accession number of CCTCCNO: V202074. Further provided...
|
|
WO/2022/183762A1 |
Disclosed are an anti-phenacetin monoclonal antibody hybridoma cell strain AD, and a preparation method therefor and the use thereof, which relate to the technical field of food safety and immunological detection. The deposit name of the...
|
|
WO/2022/183541A1 |
Provided is a codon-optimized hyaluronidase gene, and the nucleotide sequence thereof is as shown in SEQ ID NO. 1. A recombinant Pichia pastoris engineering strain, which is constructed by means of using the codon-optimized hyaluronidase...
|
|
WO/2022/183531A1 |
A cross-species cleavable Xanthomonas phage and a composition, a kit and the use thereof. The Xanthomonas axonopodis phage is the Xanthomonas phage GJ19P1 with the accession number of CCTCC NO: M 2020805; the composition at least contain...
|
|
WO/2022/184525A1 |
The present invention relates to a species of genus Pseudomonas identified as Pseudomonas BR87641, termed Candidatus Pseudomonas pretiosorbens, having Accession Deposit Number DSM 33684.
|
|
WO/2022/184746A1 |
The present application relates to novel depolymerized exopolysaccharides derived from microalgae, the method for obtaining same from microalgae, and their use for increasing the production of collagen and/or hyaluronic acid, in order to...
|
|
WO/2022/183593A1 |
Provided are a porcine alveolar macrophage healthy cell line, and a construction method and an application. The porcine alveolar macrophage healthy cell line has an accession number of CGMCC No: 21498. In the porcine alveolar macrophage ...
|
|
WO/2022/178578A1 |
The present invention relates to bacteria conferring bioprotection and/or biofertilizer properties to plants into which they are inoculated. More particularly, the present invention relates to endophyte strains of Paenibacillus sp., plan...
|
|
WO/2022/179073A1 |
Provided are an Aneurinibacillus sp. and the use thereof in the decolorization of dye wastewater. The Aneurinibacillus sp. is characterized in that: the Aneurinibacillus sp. is named Aneurinibacillus sp. YR-2, and was deposited in the Ch...
|
|
WO/2022/180534A1 |
The present invention relates to a vaccine composition comprising a host cell belonging to the genus Leishmania, wherein the host cell comprises a polynucleotide coding for at least one protein of a virus belonging to the family Coronavi...
|
|
WO/2022/179591A1 |
The present invention relates to the field of bioengineering, and specifically to genetically engineered bacillus subtilis for efficient exogenous protein expression and high-density culture. Genetic modification is performed on histidin...
|
|
WO/2022/178982A1 |
Provided are a bacterial colony formation method for sensitive and rapid culture of Helicobacter pylori and an effect evaluation method for same. The bacterial colony formation method comprises primary isolation, cryopreservation and rec...
|
|
WO/2022/174597A1 |
Provided are a genetically engineered bacterium for producing L-sarcosine, a construction method therefor and the use thereof. The genetically engineered bacterium takes escherichia coli as a host, and is obtained by means of integrating...
|
|
WO/2022/175600A1 |
A virucidal composition, a method of its manufacturing, related uses and end-user products are hereby provided. The composition comprises a mixture of biologically active substances obtainable from selected fungal strains of Ganoderma lu...
|
|
WO/2022/177569A1 |
The present disclosure describes the engineering of microbial cells for fermentative production of 3,4-dihydroxybenzoic acid and provides novel engineered microbial cells and cultures, as well as related 3,4-dihydroxybenzoic acid product...
|
|
WO/2022/175958A1 |
The present invention is in the field of biocontrol of plant insect and/or mite pests. Particularly, the present invention discloses bacterial strains effective in inhibiting the development of or in killing insects and/or mites, and/or ...
|
|
WO/2022/178432A1 |
Certain embodiments of the disclosure are related to compositions and methods for producing proteins of interest in pigment deficient Bacillus cells. Certain other embodiments are related to compositions and methods for obtaining pigment...
|
|
WO/2022/174663A1 |
A system and a method for instantly detecting nucleic acid of a pathogen. The system comprises a lysis buffer, which is used for inactivating and lysing a sample to be detected, so as to release RNA; an RT pre-mixed solution, which is us...
|
|
WO/2022/170394A1 |
The present invention provides recombinant strains of M. bovis BCG comprising a heterologous nucleic acid encoding a fusion protein, wherein the fusion protein comprises or consists of: a) a polypeptide that is at least about 80% identic...
|
|
WO/2022/172269A1 |
A method for improving a plant trait, comprising steps of: a. obtaining a plant; and b. inoculating said plant with at least one bacterium having at least one of sequences SEQ ID NO:l- SEQ ID NO: 17, as disclosed in the sequence listing ...
|
|
WO/2022/170960A1 |
Provided in the present invention are a Hypsizigus marmoreus strain, a spore, a fruiting body and the use thereof. The strain is named Finc-B-8031, belongs to Hypsizigus marmoreus, and is deposited in China General Microbiological Cultur...
|
|
WO/2022/173810A1 |
The technology described herein is directed to engineered chemoautotrophic bacteria and methods of producing triacylglycerides. Also described herein are systems or bioreactors comprising said engineered bacteria.
|
|
WO/2022/173143A1 |
The present application relates to a strain of Lactobacillus reuteri, LM1071 (KCCM12650P), and to a composition for alleviating premenstrual syndrome, comprising same. According to one embodiment of the present application, the strain of...
|
|
WO/2022/170689A1 |
Provided are a recombinant leaky strain highly expressing N-glycosylated anti-VEGFR2 monobody, a construction method therefor and use thereof. Efficient extracellular production of N-glycosylated anti-VEGFR2 monobody drug proteins and ca...
|
|
WO/2022/172007A1 |
The invention provides apparatus for implementing a computational system comprising: a colony of live microorganisms and a receptacle in which the microorganisms are able to be stimulated to cause a reaction or to modify their physiology...
|
|
WO/2022/165897A1 |
Provided are Acinetobacter vivianii, a microbial agent thereof and use thereof. The strain is named as Acinetobacter vivianii KJ-1, is deposited at China General Microbiological Culture Collection Center on 17 September 2020, and has a s...
|
|
WO/2022/166433A1 |
Use of Nat1 gene as a screening marker in genetic transformation of oomycetes. The encoding gene Nat1, which can cause resistance to nourseothricin in oomycetes, is used as a screening marker for the screening of transformants during the...
|
|
WO/2022/166398A1 |
A cysteine-rich yeast extract and a preparation method therefor. The preparation method comprises the following steps: (1) fermenting an original strain to obtain yeast milk; (2) carrying out thermal extraction and centrifugation on the ...
|
|
WO/2022/166838A1 |
Provided is a transaminase mutant, having a sequence on which an amino acid mutation takes place on the basis of the sequence as represented by SEQ ID NO: 13. Provided is an enatioselective flipped ω-transaminase ATA-117 mutant. The ami...
|
|
WO/2022/169665A1 |
The present invention is directed to virus -like particles (VLPs) which display immunogenic peptides of Flavivirus non-structural Protein 1 (NS1) derived from Dengue Virus (DENY), immunogenic compositions and vaccines against Flavivirus ...
|
|
WO/2022/166978A1 |
Provided are a genetically engineered probiotic intestinal bacterium, comprising an exogenous expression cassette comprising a nucleotide sequence that encodes acetaldehyde dehydrogenase, wherein the probiotic intestinal bacterium is Esc...
|
|
WO/2022/166459A1 |
A fermentation method for mupirocin, the method comprising performing shake flask seed culture, seed tank culture, fermentation culture, and feed culture. The fermentation method is not only suitable for industrial mass production, but a...
|
|
WO/2022/160360A1 |
Provided are lactobacillus fermentum LF-SCHY34 and an application thereof. The lactobacillus fermentum LF-SCHY34 has been preserved in China General Microbiological Culture Collection Center, with the accession number being CGMCC No. 149...
|
|
WO/2022/160495A1 |
Disclosed is a method for preparing micromolecular galactomannan and galactomannan oligosaccharides by hydrolyzing galactomannan, and a special compound enzyme therefor. The method comprises: carrying out fermentation culture by taking m...
|
|
WO/2022/161914A1 |
The present invention relates to high temperature fermentation of fine chemicals, in particular L-proline and intermediates of L-proline synthesis, and to microorganisms for such fermentation processes. The invention further relates to g...
|
|
WO/2022/160562A1 |
Provided are a lentivirus titer detection primer, a kit and a detection method. The detection kit contains a SIN vector-specific amplification primer, and the primer can only be used to detect the copy number of the lentiviral genome int...
|
|
WO/2022/163649A1 |
The purpose of the present invention is to provide: a vinegar having a higher viscosity compared to conventional vinegars; and a method for producing the same. This vinegar includes a water-soluble polysaccharide, which is PS1 (Glc : Gal...
|
